Avalo Therapeutics, Inc. ($AVTX)
Filing Information
| Accession Number | 0001918845-26-000016 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 1, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
2,037
Total Value
$16,323.16
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | May 28, 2026 | Exercise/Conversion | 679 | $8.04 | $5,459.16 | 47,801 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | May 28, 2026 | Sale | 679 | $16.00 | $10,864.00 | 47,122 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | May 28, 2026 | Exercise/Conversion | 679 | $0.00 | $0.00 | 118,321 | Direct | โ | View Details |